Literature DB >> 15254191

Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein.

Shutoku Matsuyama1, Sue Ellen Delos, Judith M White.   

Abstract

A general model has been proposed for the fusion mechanisms of class I viral fusion proteins. According to this model a metastable trimer, anchored in the viral membrane through its transmembrane domain, transits to a trimeric prehairpin intermediate, anchored at its opposite end in the target membrane through its fusion peptide. A subsequent refolding event creates a trimer of hairpins (often termed a six-helix bundle) in which the previously well-separated transmembrane domain and fusion peptide (and their attached membranes) are brought together, thereby driving membrane fusion. While there is ample biochemical and structural information on the trimer-of-hairpins conformation of class I viral fusion proteins, less is known about intermediate states between native metastable trimers and the final trimer of hairpins. In this study we analyzed conformational states of the transmembrane subunit (TM), the fusion subunit, of the Env glycoprotein of the subtype A avian sarcoma and leukosis virus (ASLV-A). By analyzing forms of EnvA TM on mildly denaturing sodium dodecyl sulfate gels we identified five conformational states of EnvA TM. Following interaction of virions with a soluble form of the ASLV-A receptor at 37 degrees C, the metastable form of EnvA TM (which migrates at 37 kDa) transits to a 70-kDa and then to a 150-kDa species. Following subsequent exposure to a low pH (or an elevated temperature or the fusion promoting agent chlorpromazine), an additional set of bands at >150 kDa, and then a final band at 100 kDa, forms. Both an EnvA C-helix peptide (which inhibits virus fusion and infectivity) and the fusion-inhibitory agent lysophosphatidylcholine inhibit the formation of the >150- and 100-kDa bands. Our data are consistent with the 70- and 150-kDa bands representing precursor and fully formed prehairpin conformations of EnvA TM. Our data are also consistent with the >150-kDa bands representing higher-order oligomers of EnvA TM and with the 100-kDa band representing the fully formed six-helix bundle. In addition to resolving fusion-relevant conformational intermediates of EnvA TM, our data are compatible with a model in which the EnvA protein is activated by its receptor (at neutral pH and a temperature greater than or equal to room temperature) to form prehairpin conformations of EnvA TM, and in which subsequent exposure to a low pH is required to stabilize the final six-helix bundle, which drives a later stage of fusion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254191      PMCID: PMC446138          DOI: 10.1128/JVI.78.15.8201-8209.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation.

Authors:  R G Paterson; C J Russell; R A Lamb
Journal:  Virology       Date:  2000-04-25       Impact factor: 3.616

2.  Reversible merger of membranes at the early stage of influenza hemagglutinin-mediated fusion.

Authors:  E Leikina; L V Chernomordik
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

3.  Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore.

Authors:  C Kozerski; E Ponimaskin; B Schroth-Diez; M F Schmidt; A Herrmann
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Role of the cytoplasmic tail of ecotropic moloney murine leukemia virus Env protein in fusion pore formation.

Authors:  G B Melikyan; R M Markosyan; S A Brener; Y Rozenberg; F S Cohen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores.

Authors:  R M Markosyan; F S Cohen; G B Melikyan
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

6.  Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein.

Authors:  W Mothes; A L Boerger; S Narayan; J M Cunningham; J A Young
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

7.  Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein.

Authors:  S E Delos; J M White
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 8.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

Authors:  J J Skehel; D C Wiley
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

9.  Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure.

Authors:  A L Maerz; R J Center; B E Kemp; B Kobe; P Poumbourios
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

10.  Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.

Authors:  G B Melikyan; R M Markosyan; H Hemmati; M K Delmedico; D M Lambert; F S Cohen
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  45 in total

1.  Receptor-triggered but alkylation-arrested env of murine leukemia virus reveals the transmembrane subunit in a prehairpin conformation.

Authors:  Michael Wallin; Maria Ekström; Henrik Garoff
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein.

Authors:  Kathryn Schornberg; Shutoku Matsuyama; Kirsten Kabsch; Sue Delos; Amy Bouton; Judith White
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy.

Authors:  Sarah A Connolly; George P Leser; Hsien-Shen Yin; Theodore S Jardetzky; Robert A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-08       Impact factor: 11.205

4.  Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.

Authors:  Makoto Ujike; Hiroki Nishikawa; Akira Otaka; Naoki Yamamoto; Norio Yamamoto; Masao Matsuoka; Eiichi Kodama; Nobutaka Fujii; Fumihiro Taguchi
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

Review 5.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Authors:  Judith M White; Sue E Delos; Matthew Brecher; Kathryn Schornberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2008 May-Jun       Impact factor: 8.250

Review 6.  Filovirus entry into cells - new insights.

Authors:  Emily Happy Miller; Kartik Chandran
Journal:  Curr Opin Virol       Date:  2012-03-23       Impact factor: 7.090

7.  Visualization of the two-step fusion process of the retrovirus avian sarcoma/leukosis virus by cryo-electron tomography.

Authors:  Giovanni Cardone; Matthew Brecher; Juan Fontana; Dennis C Winkler; Carmen Butan; Judith M White; Alasdair C Steven
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

8.  Kinetic analyses of the surface-transmembrane disulfide bond isomerization-controlled fusion activation pathway in Moloney murine leukemia virus.

Authors:  Michael Wallin; Robin Löving; Maria Ekström; Kejun Li; Henrik Garoff
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

9.  A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle.

Authors:  R M Markosyan; P Bates; F S Cohen; G B Melikyan
Journal:  Biophys J       Date:  2004-08-31       Impact factor: 4.033

10.  A charged second-site mutation in the fusion peptide rescues replication of a mutant avian sarcoma and leukosis virus lacking critical cysteine residues flanking the internal fusion domain.

Authors:  Deborah C Melder; Xueqian Yin; Sue E Delos; Mark J Federspiel
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.